RANI – rani therapeutics holdings, inc. - class a (US:NASDAQ)
Stock Stats
News
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Rani Therapeutics GAAP EPS of -$0.24 in-line [Seeking Alpha]
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update [Yahoo! Finance]
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
Rani Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Form SC 13G Rani Therapeutics Holdin Filed by: ARMISTICE CAPITAL, LLC
Form 10-Q Rani Therapeutics Holdin For: Sep 30
Form 8-K Rani Therapeutics Holdin For: Nov 14
Form SC 13D/A Rani Therapeutics Holdin Filed by: South Lake One LLC
Form 4 Rani Therapeutics Holdin For: Oct 15 Filed by: South Lake One LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.